Algo version: 0.98b
CEN Biotech, Inc. is listed at the OTC Exchange
CEN Biotech, Inc. [CENBF]
OTC Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is CEN Biotech, Inc. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for CEN Biotech, Inc. 10 years ago, but if you had invested on Monday 4th of May 2020 when the price was $2.05, you would have made a loss of $-2.05 per share or -100.00%

No, the average daily trading liquidity for CEN Biotech, Inc. is $25 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

CEN Biotech, Inc. has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.08, the company's ability to pay off the debt is limited. CEN Biotech, Inc. has a very good net profit margin of 67.46% and should have very high tolerances against inflation.

We have calculated the inflation risk for CEN Biotech, Inc. to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.